BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38671536)

  • 1. Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs.
    Kraft T; Grützmann K; Meinhardt M; Meier F; Westphal D; Seifert M
    Acta Neuropathol Commun; 2024 Apr; 12(1):67. PubMed ID: 38671536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-specific identification of genome-wide DNA-methylation differences between intracranial and extracranial melanoma metastases.
    Kraft T; Grützmann K; Meinhardt M; Meier F; Westphal D; Seifert M
    Sci Rep; 2023 Jan; 13(1):444. PubMed ID: 36624125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target.
    Chen G; Chakravarti N; Aardalen K; Lazar AJ; Tetzlaff MT; Wubbenhorst B; Kim SB; Kopetz S; Ledoux AA; Gopal YN; Pereira CG; Deng W; Lee JS; Nathanson KL; Aldape KD; Prieto VG; Stuart D; Davies MA
    Clin Cancer Res; 2014 Nov; 20(21):5537-46. PubMed ID: 24803579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases.
    Harding JJ; Catalanotti F; Munhoz RR; Cheng DT; Yaqubie A; Kelly N; McDermott GC; Kersellius R; Merghoub T; Lacouture ME; Carvajal RD; Panageas KS; Berger MF; Rosen N; Solit DB; Chapman PB
    Oncologist; 2015 Jul; 20(7):789-97. PubMed ID: 25956405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key candidate genes involved in melanoma metastasis.
    Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
    Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma.
    Wang HZ; Wang F; Chen PF; Zhang M; Yu MX; Wang HL; Zhao Q; Liu J
    Biomed Pharmacother; 2019 Mar; 111():1234-1242. PubMed ID: 30841437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic identification of miR-205 target genes potentially involved in metastasis and survival of cutaneous malignant melanoma.
    Sánchez-Sendra B; Serna E; Navarro L; González-Muñoz JF; Portero J; Ramos A; Murgui A; Monteagudo C
    Sci Rep; 2020 Mar; 10(1):4771. PubMed ID: 32179834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases.
    Westphal D; Meinhardt M; Grützmann K; Schöne L; Steininger J; Neuhaus LT; Wiegel M; Schrimpf D; Aust DE; Schröck E; Baretton GB; Beissert S; Juratli TA; Schackert GG; Gravemeyer J; Becker JC; von Deimling A; Koelsche C; Klink B; Meier F; Schulz A; Muders MH; Seifert M
    J Invest Dermatol; 2023 Jul; 143(7):1233-1245.e17. PubMed ID: 36716920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct genetic profiles of extracranial and intracranial acral melanoma metastases.
    Sharma G; Lian CG; Lin WM; Amin-Mansour A; Jané-Valbuena J; Garraway L; Bao W; Yoon CH; Ibrahim N
    J Cutan Pathol; 2016 Oct; 43(10):884-91. PubMed ID: 27251777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.
    Koh SS; Wei JP; Li X; Huang RR; Doan NB; Scolyer RA; Cochran AJ; Binder SW
    Mod Pathol; 2012 Jun; 25(6):828-37. PubMed ID: 22411186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-L1, PD-1, LAG-3, and TIM-3 in Melanoma: Expression in Brain Metastases Compared to Corresponding Extracranial Tumors.
    Wang JJ; Burger P; Taube J; Soni A; Chaichana K; Sheu M; Belcaid Z; Jackson C; Lim M
    Cureus; 2019 Dec; 11(12):e6352. PubMed ID: 31938638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.
    Marzese DM; Scolyer RA; Roqué M; Vargas-Roig LM; Huynh JL; Wilmott JS; Murali R; Buckland ME; Barkhoudarian G; Thompson JF; Morton DL; Kelly DF; Hoon DS
    Neuro Oncol; 2014 Nov; 16(11):1499-509. PubMed ID: 24968695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network-based analysis of heterogeneous patient-matched brain and extracranial melanoma metastasis pairs reveals three homogeneous subgroups.
    Grützmann K; Kraft T; Meinhardt M; Meier F; Westphal D; Seifert M
    Comput Struct Biotechnol J; 2024 Dec; 23():1036-1050. PubMed ID: 38464935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of whole brain radiation therapy in the management of melanoma brain metastases.
    Dyer MA; Arvold ND; Chen YH; Pinnell NE; Mitin T; Lee EQ; Hodi FS; Ibrahim N; Weiss SE; Kelly PJ; Floyd SR; Mahadevan A; Alexander BM
    Radiat Oncol; 2014 Jun; 9():143. PubMed ID: 24954062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases.
    Carpenter DJ; Leng J; Arshad M; Giles W; Kirkpatrick JP; Floyd SR; Chmura SJ; Salama JK; Hong JC
    JAMA Netw Open; 2023 Apr; 6(4):e2310117. PubMed ID: 37099292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases.
    Niessner H; Forschner A; Klumpp B; Honegger JB; Witte M; Bornemann A; Dummer R; Adam A; Bauer J; Tabatabai G; Flaherty K; Sinnberg T; Beck D; Leiter U; Mauch C; Roesch A; Weide B; Eigentler T; Schadendorf D; Garbe C; Kulms D; Quintanilla-Martinez L; Meier F
    Cancer Med; 2013 Feb; 2(1):76-85. PubMed ID: 24133630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?
    Tímár J; Gyorffy B; Rásó E
    Clin Exp Metastasis; 2010 Aug; 27(6):371-87. PubMed ID: 20177751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
    Jilaveanu LB; Parisi F; Barr ML; Zito CR; Cruz-Munoz W; Kerbel RS; Rimm DL; Bosenberg MW; Halaban R; Kluger Y; Kluger HM
    Clin Cancer Res; 2015 May; 21(9):2138-47. PubMed ID: 25316811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
    Wang S; Fan W; Wan B; Tu M; Jin F; Liu F; Xu H; Han P
    PLoS One; 2017; 12(2):e0172498. PubMed ID: 28225791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Core Genes and Pathways in Melanoma Metastasis via Bioinformatics Analysis.
    Xie R; Li B; Jia L; Li Y
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.